Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgia Fiorini

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Chemical Biology|February 8, 2024
Biochemistry of the hypoxia-inducible factor hydroxylasesGiorgia Fiorini, Christopher J Schofield
Biophysical Journal|October 25, 2025
Advances of 3D microcrystals electron diffraction for transmembrane protein structure determinationGiorgia Fiorini, Gebhard F X Schertler, Valérie Panneels
Chemical Communications (Cambridge, England)|June 25, 2020
Asymmetric [N-I-N]<sup>+</sup> halonium complexesJas S Ward, Giorgia Fiorini, Antonio Frontera, et al.
Scientific Reports|October 31, 2024
Human prolyl hydroxylase domain 2 reacts with O<sub>2</sub> and 2-oxoglutarate to enable formation of inactive Fe(III).2OG.hypoxia-inducible-factor α complexesGiorgia Fiorini, Stephen A Marshall, William D Figg, et al.
Proteins|July 14, 2023
Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2William D Figg, Giorgia Fiorini, Rasheduzzaman Chowdhury, et al.
Chemmedchem|September 18, 2024
Crystallographic and Selectivity Studies on the Approved HIF Prolyl Hydroxylase Inhibitors Desidustat and EnarodustatThomas P Corner, Eidarus Salah, Anthony Tumber, et al.
Chemical Science|November 16, 2023
Structure-guided optimisation of <i>N</i>-hydroxythiazole-derived inhibitors of factor inhibiting hypoxia-inducible factor-αThomas P Corner, Ryan Z R Teo, Yue Wu, et al.
Journal of Medicinal Chemistry|August 1, 2023
5-Substituted Pyridine-2,4-dicarboxylate Derivatives Have Potential for Selective Inhibition of Human Jumonji-C Domain-Containing Protein 5Lennart Brewitz, Yu Nakashima, Sonia K Piasecka, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Chemical Biology|February 8, 2024
Biochemistry of the hypoxia-inducible factor hydroxylasesGiorgia Fiorini, Christopher J Schofield
Biophysical Journal|October 25, 2025
Advances of 3D microcrystals electron diffraction for transmembrane protein structure determinationGiorgia Fiorini, Gebhard F X Schertler, Valérie Panneels
Chemical Communications (Cambridge, England)|June 25, 2020
Asymmetric [N-I-N]<sup>+</sup> halonium complexesJas S Ward, Giorgia Fiorini, Antonio Frontera, et al.
Scientific Reports|October 31, 2024
Human prolyl hydroxylase domain 2 reacts with O<sub>2</sub> and 2-oxoglutarate to enable formation of inactive Fe(III).2OG.hypoxia-inducible-factor α complexesGiorgia Fiorini, Stephen A Marshall, William D Figg, et al.
Proteins|July 14, 2023
Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2William D Figg, Giorgia Fiorini, Rasheduzzaman Chowdhury, et al.
Chemmedchem|September 18, 2024
Crystallographic and Selectivity Studies on the Approved HIF Prolyl Hydroxylase Inhibitors Desidustat and EnarodustatThomas P Corner, Eidarus Salah, Anthony Tumber, et al.
Chemical Science|November 16, 2023
Structure-guided optimisation of <i>N</i>-hydroxythiazole-derived inhibitors of factor inhibiting hypoxia-inducible factor-αThomas P Corner, Ryan Z R Teo, Yue Wu, et al.
Journal of Medicinal Chemistry|August 1, 2023
5-Substituted Pyridine-2,4-dicarboxylate Derivatives Have Potential for Selective Inhibition of Human Jumonji-C Domain-Containing Protein 5Lennart Brewitz, Yu Nakashima, Sonia K Piasecka, et al.
Pageof 1